Opportunity Information: Apply for CDC RFA DP16 1612
Apply for CDC RFA DP16 1612
- The HHS-CDC-NCCDPHP in the health sector is offering a public funding opportunity titled "Mississippi Delta Health Collaborative" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.816.
- This funding opportunity was created on May 11, 2016 and posted on May 11, 2016.
- Applicants must submit their applications by Jul 13, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $3,150,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Mississippi Delta Health Collaborative grant opportunity (CDC RFA DP16 1612) is a CDC cooperative agreement designed to reduce the heavy burden of high blood pressure in the 18-county Mississippi Delta, a largely rural and underserved region with significant health disparities. The overall aim is not just to improve individual treatment, but to support population-wide and targeted strategies that prevent and control hypertension and narrow the racial, ethnic, and socioeconomic gaps tied to uncontrolled blood pressure among adults in the region. The focus is adults living in the Delta, with particular attention to priority populations: adult subgroups experiencing uncontrolled high blood pressure alongside barriers such as inadequate access to care, lower quality of care, and broader inequities that contribute to worse outcomes.
The program requires applicants to implement two integrated components at the same time and in the same communities, so that environmental change and clinical improvement reinforce one another rather than operating in silos. Component 1 centers on environmental strategies that make healthy choices easier and more routine. This includes strengthening community environments that promote physical activity, expanding access to healthier foods and beverages with an emphasis on low- or no-sodium options (given sodiums well-established link to hypertension), and increasing tobacco- and smoke-free environments. In practice, this component points toward policy, systems, and environmental shifts in places where people live, work, and gather, aiming to change the default conditions that shape daily behaviors and cardiovascular risk.
Component 2 targets health systems and community-clinical linkages, meaning the work is expected to improve how health care settings identify, treat, and manage high blood pressure while also building stronger connections between clinics and community resources that can support patients outside the exam room. This could include strengthening referral pathways, improving follow-up and care coordination, using team-based care approaches, and ensuring that people with uncontrolled hypertension are connected to community supports that help with self-management, lifestyle change, medication adherence, and overcoming access barriers. The core expectation is that clinical improvements and community supports will be aligned with the environmental changes from Component 1, creating a more complete prevention and control strategy across the region.
A major structural feature of the opportunity is an emphasis on local implementation and regional coordination. The applicant is strongly encouraged to pass through at least 50 percent of award funds as sub-awards to local and regional entities, reflecting CDCs intent to resource community-level partners that are closest to the people and places affected. At the same time, the primary awardee must provide leadership, coordination, and technical assistance to selected communities across the Delta, ensuring the work is consistent, complementary, and strategically organized rather than fragmented. Because this is a cooperative agreement, recipients should expect substantial federal involvement typical of that funding instrument, such as collaboration on planning, performance expectations, and program direction.
Administratively, this opportunity was posted May 11, 2016, with a closing date of July 13, 2016, under HHS/CDC/NCCDPHP in the health funding category (CFDA 93.816). CDC anticipated making one award with an award ceiling of $3,150,000. Eligibility is listed broadly as "Others" with clarification referenced in the full announcement, indicating it was not limited only to a narrow class of applicants and likely depended on the specific criteria outlined in the eligibility section of the FOA. Overall, the grant is structured to drive measurable improvements in hypertension prevention and control by combining community environment changes with health system strengthening, intentionally prioritizing the populations in the Mississippi Delta who face the greatest barriers and the highest risk.
Mississippi Delta Health Collaborative (CDC RFA DP16-1612) - FAQs
What is the Mississippi Delta Health Collaborative grant opportunity?
The Mississippi Delta Health Collaborative (CDC RFA DP16-1612) is a CDC cooperative agreement focused on reducing the heavy burden of high blood pressure (hypertension) in the 18-county Mississippi Delta region. It is designed to support both population-wide and targeted strategies that prevent and control hypertension and reduce disparities tied to uncontrolled blood pressure.
What is the main goal of the program?
The overall aim is to improve hypertension prevention and control across the region, not only by improving individual treatment, but also by changing community conditions and strengthening health system practices. A core goal is to narrow racial, ethnic, and socioeconomic gaps associated with uncontrolled blood pressure among adults in the Mississippi Delta.
Who is the focus population for this opportunity?
The focus is on adults living in the Mississippi Delta. The opportunity calls for particular attention to priority adult subgroups experiencing uncontrolled high blood pressure and barriers such as inadequate access to care, lower quality of care, and broader inequities that contribute to worse outcomes.
What geographic area does the program cover?
The program is specific to the 18-county Mississippi Delta, described as a largely rural and underserved region with significant health disparities.
What kind of funding mechanism is this?
This opportunity is a CDC cooperative agreement. Under a cooperative agreement, recipients should expect substantial federal involvement typical of that funding instrument, including collaboration on planning, performance expectations, and program direction.
What are the required program components?
Applicants are required to implement two integrated components at the same time and in the same communities. The intent is for environmental change and clinical improvement to reinforce each other rather than operate separately.
What is Component 1?
Component 1 centers on environmental strategies that make healthy choices easier and more routine. This includes strengthening community environments that promote physical activity, expanding access to healthier foods and beverages with an emphasis on low- or no-sodium options, and increasing tobacco- and smoke-free environments.
Why does Component 1 emphasize low- or no-sodium options?
The program highlights low- or no-sodium options because sodium has an established link to hypertension. The intent is to support environmental changes that make lower-sodium choices more accessible in everyday settings.
What types of settings are implied for Component 1 strategies?
Component 1 points toward policy, systems, and environmental shifts in places where people live, work, and gather, with the goal of changing default conditions that shape daily behaviors and cardiovascular risk.
What is Component 2?
Component 2 targets health systems and community-clinical linkages. The work is expected to improve how health care settings identify, treat, and manage high blood pressure while also building stronger connections between clinics and community resources that can support patients outside the exam room.
What are examples of activities described under Component 2?
Examples described include strengthening referral pathways, improving follow-up and care coordination, using team-based care approaches, and ensuring people with uncontrolled hypertension are connected to community supports that help with self-management, lifestyle change, medication adherence, and overcoming access barriers.
How are Components 1 and 2 expected to work together?
The core expectation is that clinical improvements and community supports (Component 2) will be aligned with environmental changes (Component 1). Implementing both together in the same communities is intended to create a more complete prevention and control strategy across the region.
Is the program focused only on individual clinical care?
No. The opportunity emphasizes that the aim is not just to improve individual treatment. It is designed to support population-wide and targeted approaches, including environmental and systems-level changes that shape prevention and control of hypertension.
What does the opportunity say about addressing disparities?
The opportunity explicitly emphasizes narrowing racial, ethnic, and socioeconomic gaps tied to uncontrolled blood pressure among adults in the region, with attention to groups facing barriers such as limited access to care, lower quality of care, and broader inequities.
How is implementation structured across the region?
A major structural feature is local implementation combined with regional coordination. The primary awardee is expected to provide leadership, coordination, and technical assistance to selected communities across the Delta so the work is consistent and strategically organized rather than fragmented.
Does the CDC expect funds to be shared with local partners?
Yes. The applicant is strongly encouraged to pass through at least 50 percent of award funds as sub-awards to local and regional entities, reflecting CDC intent to resource community-level partners closest to affected people and places.
How many awards were anticipated?
CDC anticipated making one award under this opportunity.
What was the award ceiling?
The anticipated award ceiling was $3,150,000.
When was the opportunity posted and when did it close?
The opportunity was posted on May 11, 2016, with a closing date of July 13, 2016.
Which federal agency and program area issued the funding announcement?
The opportunity was issued under HHS/CDC/NCCDPHP and is in the health funding category.
What is the CFDA number associated with this opportunity?
The CFDA number listed for this opportunity is 93.816.
Who was eligible to apply?
Eligibility is listed broadly as "Others," with clarification referenced in the full announcement. This indicates eligibility was not limited to only a narrow class of applicants and depended on the specific criteria described in the eligibility section of the FOA.
What does "integrated components" mean in this program?
Based on the announcement summary, "integrated components" means implementing both the environmental strategies (Component 1) and the health systems/community-clinical linkage strategies (Component 2) concurrently and within the same communities, so each component strengthens the impact of the other.
What is the overall intended outcome of combining environmental change with health system strengthening?
The grant is structured to drive measurable improvements in hypertension prevention and control by combining community environment changes with health system strengthening, with intentional prioritization of populations in the Mississippi Delta facing the greatest barriers and highest risk.
Browse more opportunities from the same category: Health
Next opportunity: Cancer-related Behavioral Research through Integrating Existing Data (R21)
Previous opportunity: Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Tuberculosis Vaccine Design (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DP16 1612
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DP16 1612) also looked into and applied for these:
| Funding Opportunity |
|---|
| Public Health Preparedness and Response (PHPR) Cooperative Agreement for All-Hazards Public Health Emergencies: Zika 2016 Apply for CDC RFA TP16 1602 Funding Number: CDC RFA TP16 1602 Agency: HHS-CDC-OPHPR Category: Health Funding Amount: $5,000,000 |
| Grants for Early Medical/Surgical Subspecialists' Transition to Aging Research (GEMSSTAR) (R03) Apply for RFA AG 17 012 Funding Number: RFA AG 17 012 Agency: HHS-NIH11 Category: Health Funding Amount: $75,000 |
| From Association to Function in the Alzheimers Disease Post Genomics Era (R01) Apply for RFA AG 17 010 Funding Number: RFA AG 17 010 Agency: HHS-NIH11 Category: Health Funding Amount: $350,000 |
| Establishment of Centers of Excellence in Refugee Health Apply for CDC RFA CK15 150302CONT16 Funding Number: CDC RFA CK15 150302CONT16 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| Learning Collaboratives for Advanced Business Acumen Skills Apply for HHS 2016 ACL CIP PPBA 0181 Funding Number: HHS 2016 ACL CIP PPBA 0181 Agency: HHS-ACL Category: Health Funding Amount: $500,000 |
| Creutzfeldt - Jakob Disease (CJD) Support, Education, and Awareness Projects as Apply for CDC RFA CK15 150402CONT16 Funding Number: CDC RFA CK15 150402CONT16 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| Environmental Sampling with NAU for High Consequence Pathogens Apply for CDC RFA CK16 1606 Funding Number: CDC RFA CK16 1606 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: $300,000 |
| Children’s Hospitals Graduate Medical Education (CHGME) Payment Program Apply for HRSA 17 006 Funding Number: HRSA 17 006 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Jurisdictional Approach to Curing Hepatitis C Among HIV/HCV Coinfected People of Color - Evaluation and Technical Assistance Center Apply for HRSA 16 188 Funding Number: HRSA 16 188 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Inclusion of Mobile/e-Consents for Alzheimer's Disease Research (Admin Supp) Apply for PA 16 259 Funding Number: PA 16 259 Agency: HHS-NIH11 Category: Health Funding Amount: $100,000 |
| Jurisdictional Approach to Curing Hepatitis C among HIV/HCV Coinfected People of Color – Jurisdictional Sites Apply for HRSA 16 189 Funding Number: HRSA 16 189 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Reducing the Duration of Untreated Psychosis in the United States (R01) Apply for PAR 16 265 Funding Number: PAR 16 265 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Reducing the Duration of Untreated Psychosis in the United States (R34) Apply for PAR 16 264 Funding Number: PAR 16 264 Agency: HHS-NIH11 Category: Health Funding Amount: $225,000 |
| Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01) Apply for PAR 16 262 Funding Number: PAR 16 262 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities Outside the United States Apply for CDC RFA IP16 1603 Funding Number: CDC RFA IP16 1603 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: $400,000 |
| NHLBI Career Transition Award for Intramural Fellows (K22) Apply for PAR 16 267 Funding Number: PAR 16 267 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Surveillance and Response to Seasonal and Pandemic Influenza by Regional Offices of the World Health Organization Apply for CDC RFA IP16 1606 Funding Number: CDC RFA IP16 1606 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: $2,000,000 |
| Introducing or Expanding the Use of Seasonal Influenza Vaccines in Public Health Programs Outside of the United States Apply for CDC RFA IP16 1604 Funding Number: CDC RFA IP16 1604 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: $250,000 |
| NIAID Clinical Trial Implementation Grant (R01) Apply for PAR 16 269 Funding Number: PAR 16 269 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Partnerships for Structure-Based Design of Novel Immunogens for Vaccine Development (R01) Apply for RFA AI 16 047 Funding Number: RFA AI 16 047 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DP16 1612", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
